OHE at HTAi 2018

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June.

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2018 conference in Vancouver, 1-5 June.

Later this week, Adrian Towse, Koonal Shah, Grace Hampson, and Chris Sampson will be travelling to Vancouver, Canada, to participate in HTAi 2018 and to present some of OHE’s ongoing work. The theme for this year’s conference is Strengthening the Evidence-to-Action Connection. You can meet the team at the following sessions.

Panel: How Should We Value and Pay for New Antibiotics?

[Sunday, 10:45 AM – 12:00 PM, Cypress 1 (Level 2)]

This session will explore how the benefits of antibiotics can best be captured in HTA, and how we should pay for them when their value may depend on restricting their use. Adrian Towse, Chris Henshall, Taimur Bhatti, Judith Glennie, and Monika Schneider will be panellists.

Sponsored Symposium: Clinical, Organizational and Policy Opportunities to Tackle In-Hospital Surge of AMR

[Sunday, 12:15 PM – 1:45 PM, Cypress 2 (Level 2)]

Hospitals and intensive care units are recognised as ground for the possible development of antimicrobial resistance (AMR) and hospital-acquired infections (HAIs). Adrian Towse, Americo Cicchetti, Iñaki Gutiérrez-Ibarluzea, Roman Kozlov, Adrian Pana, and Davide Croce will explore potential initiatives in this symposium sponsored by Angelini.

Oral Presentation: Optimizing the use of RWE in HTA: Lessons From the ICER Summit

[Sunday, 2:00 PM – 4:00 PM, Salon 1 (Level 2)]

Grace Hampson will present recommendations on the roles that stakeholder groups can play in overcoming challenges associated with using real-world evidence.

Oral Presentation: Optimising Risk-Based Screening: The Case of Diabetic Eye Disease

[Sunday, 2:00 PM – 4:00 PM, Salon E (Level 1)]

In this presentation, Chris Sampson will describe the development of a decision model used to evaluate the cost-effectiveness of risk-based screening for diabetic retinopathy, and explore the potential for individualised cost-effectiveness analysis.

Poster: Long-Term Evaluation of Broad Mental Health Interventions: A Review

[Sunday, 4:00 PM – 4:30 PM, Presentation Column 11 (Level 1)]

Chris Sampson will discuss the challenges and barriers to research in the context of broad mental health interventions and make recommendations for future strategies.

Panel: From Evidence to Action When People Disagree: Societal Values and Provision of End of Life Medicines

[Monday, 11:15 AM – 12:30 PM, Oak 2 (Level 2)]

Koonal Shah will join Rachel Baker and Ailsa Brown on this panel to reflect on empirical findings and raise questions for evidence-based policy on the provision of end of life medicines.

Vignette: Developing a Value Set for the EQ-5D-Y to Support its Use in HTA

[Monday, 2:30 PM – 3:15 PM, Salon D (Level 1)]

In this presentation, Koonal Shah will summarise the challenges and ongoing work in the development of a value set for the EQ-5D-Y in the UK.

Panel: Multi-stakeholder Dialogues Addressing Needs, HTA Requirements and Good Practices in Emerging Countries

[Monday, 3:30 PM – 4:45 PM, Oak 2 (Level 2)]

Adrian Towse will join this panel with Alicia Granados, Sarah Garner, and Andre Rivire to explore the impact and actions emerging from international discussions about the role of HTA.

Panel: Building Bridges Not Walls: Can We Develop Sustainable and Sharable Cost-Effectiveness Models?

[Monday, 3:30 PM – 4:45 PM, Salon D (Level 1)]

Chris Sampson, Deborah Marshall, Stirling Bryan, and Steven Pearson will explore and identify opportunities, barriers, and future strategies for developing and implementing key infrastructure to support collaborative and transparent cost-effectiveness models.

In addition to the team’s own presentations, OHE staff have contributed to other items on the programme, which will be presented by our collaborators:

• Poster: Issues on the Estimation of the Opportunity Cost Threshold Value
  [Monday, 1:45 PM – 2:15 PM, Presentation Column 06 (Level 1)]
• Oral Presentation: Expanding Cost-Effectiveness Analysis: Measures and Methods
  [Tuesday, 8:00 AM – 9:00 AM, Salon 1 (Level 2)]